Cerus CERS
NASDAQ CERS
$2.78 -0.07 (-2.46%)
As of: Aug 20, 2026 · 3:59 PM EDT

Cerus (CERS) Total Non-Current Liabilities (2010 - 2026)

Cerus (CERS) posted Total Non-Current Liabilities of $129.3 million for Q2 2026, down 13.37% sequentially from $149.2 million in Q1 2026, and down 15.26% YoY from $152.5 million in Q2 2025.

Cerus (CERS) Total Non-Current Liabilities (2010 - 2026) Analysis & Trends

Cerus has reported Total Non-Current Liabilities for 17 years, with the latest figure at $129.3 million in Q2 2026.

  • Quarterly Total Non-Current Liabilities fell 15.26% year-over-year to $129.3 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $129.3 million (down 15.26% YoY) and the FY2025 annual result came in at $151.5 million, up 8.11% from the prior year.
  • Total Non-Current Liabilities retreated to $129.3 million in Q2 2026 per CERS's latest filing, from $149.2 million in the prior quarter.
  • Over five years, Total Non-Current Liabilities peaked at $154.0 million in Q3 2023 and troughed at $129.3 million in Q2 2026.
  • A 5-year average of $142.3 million and a median of $142.7 million in 2023 frame the typical range for Total Non-Current Liabilities.
  • The sharpest annual moves came in 2025 and 2026: Total Non-Current Liabilities advanced 15.92% in 2025, then dropped 15.26% in 2026.
  • Over 5 years, Total Non-Current Liabilities stood at $146.0 million in 2022, then slipped by 3.4% to $141.1 million in 2023, then fell by 0.66% to $140.1 million in 2024, then gained by 8.11% to $151.5 million in 2025, then fell by 14.68% to $129.3 million in 2026.
  • According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $129.3 million, $149.2 million, and $151.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn -
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn 21.28 Bn
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn 40.90 Bn
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn 42.74 Bn
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn 2.57 Bn
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn 3.68 Bn
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn 23.89 Bn
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn 9.07 Bn
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn 3.44 Bn
10 Cerus 560.58 Mn 504.32 Mn 29.53 Mn 129.25 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 129.25 Mn
Mar 31, 2026 149.20 Mn
Dec 31, 2025 151.50 Mn
Sep 30, 2025 147.76 Mn
Jun 30, 2025 152.53 Mn
Mar 31, 2025 146.51 Mn
Dec 31, 2024 140.13 Mn
Sep 30, 2024 131.46 Mn
Jun 30, 2024 131.58 Mn
Mar 31, 2024 135.54 Mn
Dec 31, 2023 141.07 Mn
Sep 30, 2023 153.99 Mn
Jun 30, 2023 144.37 Mn
Mar 31, 2023 147.36 Mn
Dec 31, 2022 146.03 Mn
Sep 30, 2022 138.08 Mn
Jun 30, 2022 136.57 Mn
Mar 31, 2022 138.22 Mn
Dec 31, 2021 149.54 Mn
Sep 30, 2021 135.47 Mn